RORγ Inhibitors for the Treatment of Autoimmune Disease
Orca Pharmaceuticals is a company based in Oxford UK developing oral drugs for the treatment of chronic inflammatory disease. Based on the pioneering work of Professor Dan Littman, we have a medicinal chemistry programme producing orally available inhibitors of RORγ, a nuclear hormone receptor found in a class of white blood cell involved autoimmune disease.
